Keyphrases
2-Deoxyglucose Uptake
40%
Acute Decompensated Heart Failure
20%
AMP Kinase
20%
Between-group
20%
Cardiac Contractility
20%
Cardiac Function
20%
Congestive Heart Failure
40%
Detrimental Effects
20%
Dilated Cardiomyopathy
100%
Exenatide
100%
Facilitative Glucose Transporter
20%
GLP-1 Receptor Agonist
20%
Glucose Homeostasis
100%
Glucose Tolerance
40%
Glucose Transporter 1 (GLUT1)
20%
Glucose Transporter 4 (GLUT4)
40%
Glucose Utilization
20%
GLUT4 Expression
20%
Heart Failure
40%
Incretin-based Therapy
20%
Insulin
20%
Insulin Resistance
60%
Insulin Sensitivity
20%
Murine Model
100%
Myocardial Glucose Uptake
40%
Pharmacologic
20%
Phosphorylation
20%
Ritonavir
20%
Twice Daily
20%
Medicine and Dentistry
Acute Decompensated Heart Failure
20%
Adenosine Phosphate
20%
Awareness
20%
Congestive Heart Failure
80%
Deoxyglucose
40%
Dilated Cardiomyopathy
100%
Exenatide
100%
Glucagon-Like Peptide-1 Agonist
20%
Glucose Homeostasis
100%
Glucose Tolerance
40%
Glucose Transporter
20%
Glucose Transporter 1
20%
Glucose Transporter 4
60%
Glucose Uptake
40%
Glucose Utilization
20%
Heart Function
20%
Heart Muscle Contractility
20%
Incretin
20%
Insulin Resistance
60%
Insulin Sensitivity
20%
Phosphotransferase
20%
Ritonavir
20%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Heart Failure
20%
Adenosine Phosphate
20%
Congestive Cardiomyopathy
100%
Congestive Heart Failure
80%
Deoxyglucose
40%
Exendin 4
100%
Glucagon Like Peptide 1 Receptor Agonist
20%
Glucose Transporter
20%
Glucose Transporter 1
20%
Glucose Transporter 4
60%
Incretin
20%
Insulin Resistance
60%
Phosphotransferase
20%
Ritonavir
20%